FindTrial
Sign In

Clinical trial to study the effect of iron supplement ferrous ascorbate on regular blood donors.

Effectiveness of ferrous ascorbate as a supplementation therapy in regular voluntaryblood donors. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073361
Enrollment
160
Registered
2024-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Neha Narwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age of donor 18-65 years, Hemoglobin 12.5-16.5 g %, weight more than 45 kg, voluntary blood donor who has donated at least three times, the last donation being within the previous year, and continues to donate regularly at least once per year and other criteria as per NACO guidelines

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Donors ferritin levels are low but their hemoglobin levels are normal,they may not be aware of this condition.Timepoint: 45 DAYS-60DAYS-90 days—

Secondary

MeasureTime frame
Donors ferritin levels will improve after taking the medicine.Timepoint: 90 DAYS—

Countries

India

Contacts

Public ContactNeha Narwal

Chitkara University,Punjab

neha.narwal207@gmail.com09466852235

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026